Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications
Qkine has raised $5.2M in total funding. The most recent round was Series B. The last funding was announced in December 2022.
Qkine's investors include Parkwalk Advisors, Martlet Capital, University of Cambridge Enterprise, Cambridge Angels group, Downing Ventures.
Qkine is headquartered in Cambridge, United Kingdom.
Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications
Qkine is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Qkine — Funding & Investors." VCBacked, December 15, 2022, https://www.vcbacked.co/company/qkine. Accessed October 29, 2026.
VCBacked. (2022). Qkine — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/qkine
{{cite web |title=Qkine — Funding & Investors |url=https://www.vcbacked.co/company/qkine |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated